Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Multiple Sclerosis Drugs Industry
Figure Multiple Sclerosis Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Multiple Sclerosis Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Multiple Sclerosis Drugs
1.2.2 Downstream
Table Application Segment of Multiple Sclerosis Drugs
Table Global Multiple Sclerosis Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Multiple Sclerosis Drugs Market by Type
3.1 By Type
3.1.1 Oral 
Table Major Company List of Oral 
3.1.2 Injectable 
Table Major Company List of Injectable 
3.1.3 Intravenous
Table Major Company List of Intravenous
3.2 Market Size
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in USD Million
Figure Global Multiple Sclerosis Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in Volume
Figure Global Multiple Sclerosis Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Biogen  (Company Profile, Sales Data etc.)
4.1.1 Biogen  Profile
Table Biogen  Overview List
4.1.2 Biogen  Products & Services
4.1.3 Biogen  Business Operation Conditions
Table Business Operation of Biogen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Teva Pharmaceutical  (Company Profile, Sales Data etc.)
4.2.1 Teva Pharmaceutical  Profile
Table Teva Pharmaceutical  Overview List
4.2.2 Teva Pharmaceutical  Products & Services
4.2.3 Teva Pharmaceutical  Business Operation Conditions
Table Business Operation of Teva Pharmaceutical  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Merck KGaA  (Company Profile, Sales Data etc.)
4.3.1 Merck KGaA  Profile
Table Merck KGaA  Overview List
4.3.2 Merck KGaA  Products & Services
4.3.3 Merck KGaA  Business Operation Conditions
Table Business Operation of Merck KGaA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novartis  (Company Profile, Sales Data etc.)
4.4.1 Novartis  Profile
Table Novartis  Overview List
4.4.2 Novartis  Products & Services
4.4.3 Novartis  Business Operation Conditions
Table Business Operation of Novartis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Bayer  (Company Profile, Sales Data etc.)
4.5.1 Bayer  Profile
Table Bayer  Overview List
4.5.2 Bayer  Products & Services
4.5.3 Bayer  Business Operation Conditions
Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sanofi  (Company Profile, Sales Data etc.)
4.6.1 Sanofi  Profile
Table Sanofi  Overview List
4.6.2 Sanofi  Products & Services
4.6.3 Sanofi  Business Operation Conditions
Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Acorda Therapeutics  (Company Profile, Sales Data etc.)
4.7.1 Acorda Therapeutics  Profile
Table Acorda Therapeutics  Overview List
4.7.2 Acorda Therapeutics  Products & Services
4.7.3 Acorda Therapeutics  Business Operation Conditions
Table Business Operation of Acorda Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Questcor Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Questcor Pharmaceuticals Profile
Table Questcor Pharmaceuticals Overview List
4.8.2 Questcor Pharmaceuticals Products & Services
4.8.3 Questcor Pharmaceuticals Business Operation Conditions
Table Business Operation of Questcor Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Multiple Sclerosis Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Multiple Sclerosis Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Multiple Sclerosis Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Multiple Sclerosis Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Multiple Sclerosis Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Multiple Sclerosis Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Multiple Sclerosis Drugs Market Concentration, in 2020
Figure Europe Multiple Sclerosis Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Multiple Sclerosis Drugs MMarket Concentration, in 2020
Figure South America Multiple Sclerosis Drugs Market Concentration, in 2020
Figure Middle East & Africa Multiple Sclerosis Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacy 
Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2016-2020, in USD Million
Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacy 
Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2016-2020, in USD Million
Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2016-2020, in Volume
6.1.3 Demand in Online Pharmacy
Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2016-2020, in USD Million
Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Multiple Sclerosis Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Multiple Sclerosis Drugs Market Share in 2026, by Application, in USD Million
Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Multiple Sclerosis Drugs Market Growth 2021-2026, by Application, in Volume
Table Multiple Sclerosis Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in USD Million
Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in USD Million
Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in Volume
Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Multiple Sclerosis Drugs
2. Table Application Segment of Multiple Sclerosis Drugs
3. Table Global Multiple Sclerosis Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Injectable 
5. Table Major Company List of Intravenous
6. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in USD Million
7. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in Volume
8. Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in Volume
10. Table Biogen  Overview List
11. Table Business Operation of Biogen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Teva Pharmaceutical  Overview List
13. Table Business Operation of Teva Pharmaceutical  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Merck KGaA  Overview List
15. Table Business Operation of Merck KGaA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Novartis  Overview List
17. Table Business Operation of Novartis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Bayer  Overview List
19. Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Sanofi  Overview List
21. Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Acorda Therapeutics  Overview List
23. Table Business Operation of Acorda Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Questcor Pharmaceuticals Overview List
25. Table Business Operation of Questcor Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Global Multiple Sclerosis Drugs Sales Revenue 2016-2020, by Company, in USD Million
27. Table Global Multiple Sclerosis Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
28. Table Global Multiple Sclerosis Drugs Sales Volume 2016-2020, by Company, in Volume
29. Table Global Multiple Sclerosis Drugs Sales Volume Share 2016-2020, by Company, in Volume
30. Table Regional Demand Comparison List
31. Table Major Application in Different Regions
32. Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in USD Million
33. Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in Volume
34. Table Multiple Sclerosis Drugs Market Growth 2021-2026, by Application, in Volume
35. Table Multiple Sclerosis Drugs Market Share in 2026, by Application, in Volume
36. Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in USD Million
37. Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in Volume
38. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in USD Million
39. Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in USD Million
40. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in Volume
41. Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in Volume
42. Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
43. Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
44. Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
45. Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
46. Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
47. Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
48. Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
49. Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
50. Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
51. Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
52. Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in USD Million
53. Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in Volume
54. Table Price Factors List